Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.57 |
| ▸ | SELP | P16109 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | BLVRB | P30043 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.41 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.41 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8374984 | 0.88 | SELL (0.50) | SELLSELPCA12CA1CA2 | |
| SCHEMBL31668786 | 0.86 | SELL (0.48) | SELLSELPCSNK2A1MEN1KDR | |
| SCHEMBL542401 | 0.86 | SELL (0.48) | SELLSELPCSNK2A1MEN1KDR | |
| SCHEMBL40220 | 0.85 | SELL (0.53) | SELLSELPCSNK2A1KAT8MCL1 | |
| SCHEMBL15255722 | 0.84 | HSD17B1 (0.43) | SELLSELPMEN1HTTKMT2A | |
| SCHEMBL31336021 | 0.84 | SELL (0.57) | SELLSELPCSNK2A1MEN1PDE4A | |
| SCHEMBL9874859 | 0.84 | SELL (0.57) | SELLSELPCSNK2A1MEN1PDE4A | |
| SCHEMBL294836 | 0.83 | CYP1A2 (0.50) | SELLSELPMEN1KMT2ACA12 | |
| SCHEMBL18419577 | 0.82 | SELL (0.45) | SELLSELPCSNK2A1MEN1KDR | |
| SCHEMBL8029592 | 0.82 | ALDH1A1 (0.50) | SELLSELPCSNK2A1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900236-B1 | TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION | UNIV BIRMINGHAM (GB) | 2019-01-16 | — | — | EP | claimed |
| EP-1676591-B1 | Compositions and methods to create a vascularized environment for cellular transplantation | LIFESCAN INC (US) | 2018-08-01 | — | — | EP | claimed |
| US-20130267594-A1 | PROLYL HYDROXYLASE INHIBITORS AS RADIATION MITIGATORS AND RADIATION PROTECTORS | DANA-FARBER CANCER INSTITUTE INC. (US) | 2013-10-10 | — | — | US | claimed |
| WO-2012037212-A1 | PROLYL HYDROXYLASE INHIBITORS AS RADIATION MITIGATORS AND RADIATION PROTECTORS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2012-03-22 | — | — | WO | claimed |
| US-20070122448-A1 | Compositions and methods to create a vascularized environment for cellular transplantation | REZANIA ALIREZA | 2007-05-31 | — | — | US | claimed |
| EP-1676591-A2 | Compositions and methods to create a vascularized environment for cellular transplantation | LIFESCAN, INC. (US) | 2006-07-05 | — | — | EP | claimed |
| EP-1006403-B1 | Use of direct thermal transparent imaging materials including an organic silver salt for producing labels | AGFA GEVAERT (BE) | 2004-10-20 | — | — | EP | claimed |
| EP-1006405-B1 | Black and white thermographic recording material with improved image tone | AGFA GEVAERT (BE) | 2003-07-23 | — | — | EP | claimed |
| US-20260102484-A1 | ADJUVANTS FOR ENHANCING THE IMMUNE RESPONSE | LANKENAU INSTITUTE FOR MEDICAL RESEARCH (US) | 2026-04-16 | — | — | US | disclosed |
| CN-121795492-A | Post-harvest fruit preservative fresh-keeping composite bacteriostatic agent and preparation method and application thereof | 昆明理工大学 | 2026-04-07 | — | — | CN | disclosed |
| EP-4599856-A1 | SCAR REDUCING WOUND CLOSURE MATERIALS | Lankenau Institute for Medical Research (US) | 2025-08-13 | — | — | EP | disclosed |
| EP-4587049-A1 | ADJUVANTS FOR ENHANCING THE IMMUNE RESPONSE | Lankenau Institute for Medical Research (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119386094-A | Method for optimizing shinyleaf yellowhorn tea extraction process | 内蒙古民族大学 | 2025-02-07 | — | — | CN | disclosed |
| US-5589317-A | Thermal transfer imaging process | AGFA-GEVAERT N.V. (BE) | 1996-12-31 | — | — | US | disclosed |
| EP-0671283-A1 | Thermal transfer imaging process | AGFA-GEVAERT N.V. (BE) | 1995-09-13 | — | — | EP | disclosed |
| US-5084593-A | Cyanine, aniline dyes for heat sensitive recording elements | RICOH COMPANY, LTD. (JP) | 1992-01-28 | — | — | US | disclosed |
| US-5008238-A | Thermosensitive material with phenolic developer | RICOH COMPANY, LTD. (JP) | 1991-04-16 | — | — | US | disclosed |
| WO-1988002047-A1 | METHOD AND PRODUCTS FOR SIZING PAPER AND SIMILAR MATERIALS | WEYERHAEUSER COMPANY (US) | 1988-03-24 | — | — | WO | disclosed |
| US-4188390-A | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines | PFIZER INC. (US) | 1980-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102484-A1 | ADJUVANTS FOR ENHANCING THE IMMUNE RESPONSE | HIF1A, HIF1AN, EGLN3 | SELL 3013/4885SELP 1790/4885CSNK2A1 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.